Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Isoniazid 30mg/5ml oral solution
0501090K0AACQCQ
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
|
Isoniazid 375mg/5ml oral solution
0501090K0AACMCM
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
|
Isoniazid 400mg/5ml oral solution
0501090K0AACJCJ
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
|
Isoniazid 40mg/5ml oral solution
0501090K0AACPCP
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
|
Isoniazid 500mg/5ml oral solution
0501090K0AABYBY
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
|
Isoniazid 50mg/2ml solution for injection ampoules
0501090K0AAADAD
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
|
Isoniazid 50mg/5ml oral suspension
0501090K0AABIBI
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
|
Isoniazid 60mg/5ml oral solution
0501090K0AABXBX
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
|
Isoniazid 75mg/5ml oral liquid
0501090K0AABVBV
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
|
Isoniazid 80mg/5ml oral solution
0501090K0AACCCC
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
|
Isoniazid 85mg/5ml oral solution
0501090K0AACTCT
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
|
Isoniazid 87.5mg/5ml oral solution
0501090K0AABRBR
|
Isoniazid (Systemic) | Isoniazid | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.